# Dyslipidemia of Obesity Intervention in Teens

Study · id `cardio:ct-nct02956590` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02956590](<https://clinicaltrials.gov/study/NCT02956590>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02956590

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.

## Technical summary

Registry record NCT02956590. Randomized; quadruple masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2023-04-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 122 participants (enrolled count; ClinicalTrials.gov record NCT02956590, source copy `cardio:ctgov-nct02956590-2024-07-05`, retrieved 2026-10-31)
- Started: 2018-05-01 (actual) (ClinicalTrials.gov record NCT02956590, source copy `cardio:ctgov-nct02956590-2024-07-05`, retrieved 2026-10-31)
- Primary completion: 2023-04-21 (actual) (ClinicalTrials.gov record NCT02956590, source copy `cardio:ctgov-nct02956590-2024-07-05`, retrieved 2026-10-31)
- Completion: 2023-06-30 (actual) (ClinicalTrials.gov record NCT02956590, source copy `cardio:ctgov-nct02956590-2024-07-05`, retrieved 2026-10-31)
- Countries: United States; Canada (ClinicalTrials.gov record NCT02956590, source copy `cardio:ctgov-nct02956590-2024-07-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02956590-2024-07-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Dyslipidemia of Obesity Intervention in Teens
- Acronym: DO IT!
- Condition: Dyslipidemia
- Condition: Obesity
- Intervention (Drug): Pitavastatin
- Intervention (Drug): Placebo
- Lead sponsor: Carelon Research
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry intervention name matches this record: Pitavastatin (`cardio:pitavastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Carelon Research (`cardio:org-carelon-research`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: acb2457eb8a6d14e3fdbf0504f47182c30901095b162c2c6fc17ef9ecec744d6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
